Tirbanibulin

(Klisyri®)

Tirbanibulin

Drug updated on 11/15/2023

Dosage FormOintment (topical: 1%)
Drug ClassMicrotubule inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the topical treatment of actinic keratosis of the face or scalp.

Product Monograph / Prescribing Information

Document TitleYearSource
Klisyri (tirbanibulin) Prescribing Information.2021Almirall, LLC, Exton, PA

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines

Document TitleYearSource
Guidelines of care for the management of actinic keratosis.2021Journal of the American Academy of Dermatology